Members of the Science Bridges China team have returned to the UK following a very busy and rewarding visit to China.
The visit was fuelled with exciting meetings and opportunities for the University of Bradford to continue and start new work.
Reviews of the first Changzhou innovation workshop that happened last year, as well as planning meetings for the innovation workshops due to take place in April and took place with Changzhou Science & Technology Commission
Meetings were held with Suzhou Industrial Park (SIP) Science & Technology Commission to discuss in detail the arrangement for the business and academic match making event to be held on 15 and 16 April.
Paul and Qun attended an evening reception hosted by the Deputy Mayor of Guangzhou accompanied by senior officials from Guangzhou Science and Technology Bureau and representatives from Guangzhou BioIsland.
This provided an opportunity to meet fellow delegates on the UK bioscience mission, consisting of;
- Jane Grady and Allan Syms from UKTI
- Dr. David Tapolczay, CEO of MRC Technologies
- Dr Ruth McKearnan, SVP Pfizer
- David Wilkinson, Global Product Director, AstraZeneca
- Professor Graham Ball, Nottingham Trent University and CompanDX
- Dr Jiansheng Du, R&D Specialist, UKTI
- David Ratcliffe, First Secretary
- Dr Anna Zhao, Trade & Investment Manager, British Embassy Beijing
- Paul Wills, Consul Trade & Investment
Whilst in Beijing we also met with the China National Centre for Biotechnology Development (CNCBD), under Ministry of Science and Technology (MOST).
Various meetings were held in Shanghai including, meetings with Jiaotong School of Medicine, Xiaoming Shen, Vice Mayor, Shanghai Bio Office and the Senior Vice President GSK R&D and Head GSK R&D Centre China. We also visited Fudan University Institute of Biomedical Sciences.
Visit to Suzhou Biobay. Suzhou Biobay, an incubator park within Suzhou High Technology Zone, they have recruited over 200 companies to locate there in under four years. Also had a visit to Suzhou University where they have some impressive life science research capabilities, and we invited them to participate in our forthcoming open innovation workshop to be held in April, on the topic of ‘Biomedical Materials and repair’.